Traws Pharma Statistics

Total Valuation

Traws Pharma has a market cap or net worth of $16.95 million. The enterprise value is -$3.87 million.

Market Cap	16.95M
Enterprise Value	-3.87M

Important Dates

The last earnings date was Tuesday, April 16, 2024, before market open.

Earnings Date	Apr 16, 2024
Ex-Dividend Date	n/a

Share Statistics

Traws Pharma has 25.30 million shares outstanding. The number of shares has increased by 0.39% in one year.

Shares Outstanding	25.30M
Shares Change (YoY)	+0.39%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	75.01
Forward PS	276.99
PB Ratio	1.59
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.46, with zero debt.

Current Ratio	2.46
Quick Ratio	2.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -113.20% and return on invested capital (ROIC) is -190.20%.

Return on Equity (ROE)	-113.20%
Return on Assets (ROA)	-65.80%
Return on Capital (ROIC)	-190.20%
Revenue Per Employee	$13,294
Profits Per Employee	-$1.11M
Employee Count	17
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.96% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	-5.96%
50-Day Moving Average	0.81
200-Day Moving Average	0.79
Relative Strength Index (RSI)	32.77
Average Volume (30 Days)	126,995

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Traws Pharma had revenue of $226,000 and -$18.95 million in losses. Loss per share was -$0.90.

Revenue	226,000
Gross Profit	226,000
Operating Income	-20.30M
Pretax Income	-18.95M
Net Income	-18.95M
EBITDA	-18.93M
EBIT	-18.95M
Loss Per Share	-$0.90

Full Income Statement

Balance Sheet

The company has $20.82 million in cash and no debt, giving a net cash position of $20.82 million or $0.82 per share.

Cash & Cash Equivalents	20.82M
Total Debt	n/a
Net Cash	20.82M
Net Cash Per Share	$0.82
Equity / Book Value	10.67M
Book Value Per Share	0.42
Working Capital	13.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.93 million and capital expenditures -$14,000, giving a free cash flow of -$17.95 million.

Operating Cash Flow	-17.93M
Capital Expenditures	-14,000
Free Cash Flow	-17.95M
FCF Per Share	-$0.86

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -8,981.42% and -8,384.07%.

Gross Margin	100.00%
Operating Margin	-8,981.42%
Pretax Margin	-8,384.07%
Profit Margin	-8,384.07%
EBITDA Margin	-8,376.99%
EBIT Margin	-8,384.07%
FCF Margin	-7,940.71%

Dividends & Yields

Traws Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.39%
Shareholder Yield	-0.39%
Earnings Yield	-111.78%
FCF Yield	-105.87%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Traws Pharma has an Altman Z-Score of -30.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-30.98
Piotroski F-Score	2